Management of dyslipidemia in adults with diabetes

Diabetes Care

Volumn 21, Issue SUPPL. 1, 1998, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DYSLIPIDEMIA; HUMAN; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031975987     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.s36     Document Type: Review

References (7)

1. Haffner SM: Management of dyslipidemia in adults with diabetes. (Technical Review). Diabetes Care 21:160-178, 1998
2. American Diabetes Association: Nutrition recommendation and principles for people with diabetes mellitus (Position Statement). Diabetes Care 21:S32-S35, 1998
3. American Diabetes Association: Diabetes and exercise (Position Statement). Diabetes Care 21:S40-S44, 1998
4. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosaJ, Ockene IS, Pearson TA, Reed J, Smith SC, Washington R: When to start cholesterol-lowering therapy in patients with coronary heart disease: a statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation 95:1683-1685, 1997
5. Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Treatment recommendations of the National Cholesterol Education Program Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89 (Suppl.):525-584, 1992
6. National Cholesterol Education Program (NCEP) Expert Panel: Summary of the second report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol (Adult Treatment Panel II). JAMA 209:3015-3023, 1993
7. American Diabetes Association: Detection and management of lipid disorders in diabetes (Consensus Statement). Diabetes Care 16:828-834, 1993